Related references
Note: Only part of the references are listed.Green Chemistry in the Synthesis of Pharmaceuticals
Supratik Kar et al.
CHEMICAL REVIEWS (2022)
Development of inhibitors targeting glycogen synthase kinase-3β for human diseases: Strategies to improve selectivity
Junxia Wei et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability
Stefano Federico et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Targeting the interaction of β-catenin and TCF/LEF transcription factors to inhibit oncogenic Wnt signaling
Emma M. R. Koelman et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2022)
Superior Properties of N-Acetylcysteine Ethyl Ester over N-Acetyl Cysteine to Prevent Retinal Pigment Epithelial Cells Oxidative Damage
Gian Marco Tosi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
An updated research of glycogen synthase kinase-3β inhibitors: a review
Shan-Kui Liu et al.
MONATSHEFTE FUR CHEMIE (2021)
GSK3β, a Master Kinase in the Regulation of Adult Stem Cell Behavior
Claire Racaud-Sultan et al.
CELLS (2021)
A β-catenin-driven switch in TCF/LEF transcription factor binding to DNA target sites promotes commitment of mammalian nephron progenitor cells
Qiuyu Guo et al.
ELIFE (2021)
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents
Alessandro Grillo et al.
ACS CHEMICAL NEUROSCIENCE (2021)
Revisiting the Proposition of Binding Pockets and Bioactive Poses for GSK-3β Allosteric Modulators Addressed to Neurodegenerative Diseases
Guilherme M. Silva et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors
Giuseppe Campiani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
3-Amino-alkylated indoles: unexplored green products acting as anti-inflammatory agents
Sarah Mazzotta et al.
FUTURE MEDICINAL CHEMISTRY (2020)
The apoptotic effect of GSK-3 inhibitors: BIO and CHIR 98014 on H1975 lung cancer cells through ROS generation and mitochondrial dysfunction
Theodore Lemuel Mathuram et al.
BIOTECHNOLOGY LETTERS (2020)
Discovery of Novel Imidazopyridine GSK-3β Inhibitors Supported by Computational Approaches
Rosa Buonfiglio et al.
MOLECULES (2020)
Retinitis Pigmentosa and Retinal Degenerations: Deciphering Pathways and Targets for Drug Discovery and Development
Gabriele Carullo et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Design, synthesis and biological evaluation of diamino substituted cyclobut-3-ene-1,2-dione derivatives for the treatment of drug-resistant tuberculosis
Peng Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Squaramides as Bioisosteres in Contemporary Drug Design
Kylie A. Agnew-Francis et al.
CHEMICAL REVIEWS (2020)
Canonical Wnt Pathway Controls mESC Self-Renewal Through Inhibition of Spontaneous Differentiation via β-Catenin/TCF/LEF Functions
Francesco Aulicino et al.
STEM CELL REPORTS (2020)
The Versatility of Squaramides: From Supramolecular Chemistry to Chemical Biology
Luke A. Marchetti et al.
CHEM (2019)
Quercetin-3-Oleate Contributes to Skin Wound Healing Targeting FFA1/GPR40
Gabriele Carullo et al.
CHEMISTRYSELECT (2019)
Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions
A. Prasanth Saraswati et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa
Alonso Sanchez-Cruz et al.
MOLECULAR NEURODEGENERATION (2018)
First dual AK/GSK-3β inhibitors endowed with antioxidant properties as multifunctional, potential neuroprotective agents
Simone Brogi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Small molecules targeting glycogen synthase kinase 3 as potential drug candidates for the treatment of retinitis pigmentosa
Miguel Marchena et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Subtly Modulating Glycogen Synthase Kinase 3 β: Allosteric Inhibitor Development and Their Potential for the Treatment of Chronic Diseases
Valle Palomo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Activation of the Wnt Pathway by Small Peptides: Rational Design, Synthesis and Biological Evaluation
Simone Brogi et al.
CHEMMEDCHEM (2017)
Site-directed Mutagenesis of Key Residues Unveiled a Novel Allosteric Site on Human Adenosine Kinase for Pyrrolobenzoxa(thia)zepinone Non-Nucleoside Inhibitors
Lida Savi et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2016)
A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin
Jhanelle E. Gray et al.
INVESTIGATIONAL NEW DRUGS (2015)
pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
Douglas E. V. Pires et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
FAF-Drugs3: a web server for compound property calculation and chemical library design
David Lagorce et al.
NUCLEIC ACIDS RESEARCH (2015)
One-pot synthesis of unsymmetrical squaramides
Juan V. Alegre-Requena et al.
RSC ADVANCES (2015)
Cell Uptake and Localization Studies of Squaramide Based Fluorescent Probes
Angel Sampedro et al.
BIOCONJUGATE CHEMISTRY (2014)
Novel benzothiazinones (BTOs) as allosteric modulator or substrate competitive inhibitor of glycogen synthase kinase 3β (GSK-3β) with cellular activity of promoting glucose uptake
Peng Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
GSK-3-at the crossroads of cell death and survival
Ulrich Maurer et al.
JOURNAL OF CELL SCIENCE (2014)
Activator or inhibitor? GSK-3 as a new drug target
Fumi Takahashi-Yanaga
BIOCHEMICAL PHARMACOLOGY (2013)
Lessons Learnt from Glycogen Synthase Kinase 3 Inhibitors Development for Alzheimer's Disease
Ana Martinez et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Squaric acid/4-aminoquinoline conjugates: Novel potent antiplasmodial agents
Carlos J. A. Ribeiro et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Non-Nucleoside Inhibitors of Human Adenosine Kinase: Synthesis, Molecular Modeling, and Biological Studies
Stefania Butini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Exploring the Binding Sites of Glycogen Synthase Kinase 3. Identification and Characterization of Allosteric Modulation Cavities
Valle Palomo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
3-Aryl-4-(arylhydrazono)-1H-pyrazol-5-ones: Highly ligand efficient and potent inhibitors of GSK3β
Michael Arnost et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Discovery of Novel GSK-3β Inhibitors with Potent in Vitro and in Vivo Activities and Excellent Brain Permeability Using Combined Ligand- and Structure-Based Virtual Screening
Mohammad A. Khanfar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
GSK3: a multifaceted kinase in Wnt signaling
Dianqing Wu et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
FAF-Drugs2: Free ADME/tox filtering tool to assist drug discovery and chemical biology projects
David Lagorce et al.
BMC BIOINFORMATICS (2008)
Activation of canonical Wnt pathway promotes proliferation of retinal stem cells derived from adult mouse ciliary margin
T Inoue et al.
STEM CELLS (2006)
Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements
MT Veeman et al.
CURRENT BIOLOGY (2003)
Crystal structure of glycogen synthase kinase 3β:: Structural basis for phosphate-primed substrate specificity and autoinhibition
R Dajani et al.
CELL (2001)
Share Paper
